Denosumab in Primary Hyperparathyroidism

NCT01558115 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Primary Hyperparathyroidism

Interventions

DRUG: Denosumab
OTHER: Placebo

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]
[object Object]